Fixed-dose sirolimus with reduced dose calcineurin inhibitor: the University of Colorado experience.
Wiseman
A C
AC
Division of Nephrology, University of Colorado Health Sciences Center, Denver, Colorado, USA. alexander.wiseman@uchsc.edu
Kam
I
I
Christians
U
U
Jani
A
A
Bak
T
T
Wachs
M
M
Chan
L
L
D065095:Calcineurin Inhibitors; D003120:Colorado; D016572:Cyclosporine / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006785:Hospitals, University; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D016035:Pancreas Transplantation / Q000276:immunology / Q000502:physiology*; D012189:Retrospective Studies; D020123:Sirolimus / Q000627:therapeutic use*; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use
D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D020123:Sirolimus; D016559:Tacrolimus